Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 14.79%218.33B | -0.83%799.76B | 3.67%200.77B | -3.12%207.06B | -7.53%201.73B | 5.14%190.21B | 20.30%806.45B | 10.97%193.67B | 27.41%213.72B | 31.90%218.16B |
Cost of revenue | 8.47%166.62B | -1.00%629.05B | 0.88%156.41B | -3.55%160.44B | -6.02%158.6B | 5.73%153.61B | 16.86%635.43B | 10.16%155.05B | 21.55%166.34B | 25.16%168.75B |
Gross profit | 41.28%51.71B | -0.18%170.71B | 14.88%44.36B | -1.60%46.62B | -12.71%43.13B | 2.75%36.6B | 35.10%171.02B | 14.37%38.61B | 53.41%47.38B | 61.57%49.41B |
Operating expense | 13.44%27.25B | 0.36%101.22B | 5.44%26.32B | -0.63%25.96B | -2.04%24.93B | -1.26%24.03B | 14.22%100.86B | 6.56%24.96B | 21.31%26.12B | 17.44%25.45B |
Staff costs | ---- | 5.10%45.04B | ---- | ---- | ---- | ---- | 11.84%42.86B | ---- | ---- | ---- |
Selling and administrative expenses | ---- | -16.77%19.49B | ---- | ---- | ---- | ---- | 14.49%23.42B | ---- | ---- | ---- |
-General and administrative expense | ---- | -16.77%19.49B | ---- | ---- | ---- | ---- | 14.49%23.42B | ---- | ---- | ---- |
Other operating expenses | ---- | 6.10%36.69B | ---- | ---- | ---- | ---- | 17.13%34.58B | ---- | ---- | ---- |
Operating profit | 94.50%24.45B | -0.97%69.48B | 32.13%18.04B | -2.78%20.67B | -24.03%18.21B | 11.39%12.57B | 83.25%70.16B | 32.05%13.65B | 127.32%21.26B | 168.80%23.97B |
Net non-operating interest income (expenses) | -7.63%-564M | -28.40%-3.06B | -49.31%-978M | -28.42%-741M | -37.80%-813M | 6.09%-524M | -9.53%-2.38B | -27.68%-655M | -7.05%-577M | -6.69%-590M |
Non-operating interest income | 4.57%366M | 13.17%765M | -122.19%-69M | 53.37%250M | 95.00%234M | 326.83%350M | 108.64%676M | 148.80%311M | 219.61%163M | 57.89%120M |
Non-operating interest expense | 6.41%930M | 25.03%3.82B | -5.90%909M | 33.92%991M | 47.46%1.05B | 36.56%874M | 22.39%3.06B | 51.41%966M | 25.42%740M | 12.88%710M |
Net investment income | -43.60%2.25B | 698.97%3.88B | 522.11%1.18B | 32.84%-1.97B | -67.01%678M | 240.63%3.98B | -27.61%485M | -14.03%190M | -3,761.25%-2.93B | 872.56%2.06B |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 1.2B | 90.31%668M | 303.85%525M | 25M | -59.03%118M | 0 | 351M | 130M | 0 | 288M |
Income from associates and other participating interests | 20.99%536M | 29.54%2.66B | 3,652.17%817M | 106.06%680M | 5.09%722M | -58.25%443M | -2.28%2.06B | -109.02%-23M | -71.99%330M | 86.18%687M |
Special income (charges) | -2,567.74%-827M | 64.66%-6.19B | 76.44%-4.62B | -351.35%-835M | -130.23%-702M | 8.82%-31M | -199.53%-17.51B | -327.29%-19.61B | -104.73%-185M | -54.84%2.32B |
Less:Restructuring and mergern&acquisition | 2,409.68%778M | 120.00%2.29B | 1,145.31%1.59B | -39.54%185M | 0.42%478M | -76.15%31M | -70.29%1.04B | -95.93%128M | 130.08%306M | 423.08%476M |
Less:Other special charges | --49M | 120.61%582M | 116.48%591M | ---- | ---- | ---- | 87.11%-2.82B | 102.23%273M | 97.01%-124M | 48.02%-2.81B |
Less:Write off | ---- | -82.80%3.32B | -87.33%2.43B | 21,866.67%659M | 1,623.08%224M | --0 | 2,258.07%19.29B | 4,168.22%19.21B | -96.88%3M | -92.57%13M |
Other non-operating income (expenses) | 55.41%-367M | -33.24%-3.23B | 24.76%-857M | -77.78%-1.31B | -262.12%-239M | -70.75%-823M | 49.48%-2.43B | 34.88%-1.14B | 40.96%-738M | 93.69%-66M |
Income before tax | 70.80%26.68B | 26.55%64.22B | 289.28%14.11B | -3.76%16.52B | -37.31%17.97B | 26.23%15.62B | -1.81%50.74B | -143.40%-7.46B | 34.75%17.16B | 128.15%28.66B |
Income tax | 63.14%6.64B | 35.83%11.1B | 36.53%-1.41B | 179.23%5.12B | -30.17%3.32B | 6.96%4.07B | -29.20%8.17B | -154.92%-2.22B | -47.67%1.83B | 200.25%4.75B |
Net income | 73.50%20.03B | 24.77%53.11B | 396.47%15.52B | -25.67%11.39B | -38.72%14.65B | 34.77%11.55B | 6.07%42.57B | -139.85%-5.24B | 66.07%15.33B | 117.74%23.91B |
Net income continuous operations | 73.50%20.03B | 24.77%53.11B | 396.47%15.52B | -25.65%11.4B | -38.72%14.65B | 34.79%11.55B | 6.08%42.57B | -139.85%-5.24B | 66.06%15.33B | 117.76%23.91B |
Noncontrolling interests | 111.75%919M | 25.15%2.1B | -18.01%305M | 25.97%781M | 53.03%580M | 41.37%434M | 62.91%1.68B | 73.02%372M | 158.33%620M | 4.99%379M |
Net income attributable to the company | 72.00%19.11B | 24.75%51.01B | 371.44%15.21B | -27.83%10.61B | -40.20%14.07B | 34.53%11.11B | 4.58%40.89B | -143.37%-5.61B | 63.60%14.71B | 121.58%23.53B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 72.00%19.11B | 24.75%51.01B | 371.44%15.21B | -27.83%10.61B | -40.20%14.07B | 34.53%11.11B | 4.58%40.89B | -143.37%-5.61B | 63.60%14.71B | 121.58%23.53B |
Gross dividend payment | ||||||||||
Basic earnings per share | 71.98%69.29 | 24.75%184.96 | 371.24%55.17 | -27.85%38.48 | -40.20%51.02 | 34.48%40.29 | 4.53%148.27 | -143.39%-20.34 | 63.59%53.33 | 121.50%85.32 |
Diluted earnings per share | 71.98%69.29 | 24.75%184.96 | 371.20%55.163 | -27.85%38.48 | -40.20%51.02 | 34.48%40.29 | 4.53%148.27 | -143.39%-20.34 | 63.59%53.33 | 121.50%85.32 |
Dividend per share | 0 | 83.33%55 | 91.18%32.5 | 0 | 73.08%22.5 | 0 | 200.00%30 | 70.00%17 | 0 | 13 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |